Skip to content

13F-HR/A filed by Broadfin Capital, LLC

Broadfin Capital, LLC filed this 13F-HR/A for the quarter ended 2013-12-31, filed 2014-02-28, with 60 holding rows worth $758,193,000.

Accession
0000919574-14-002012
Filed
2014-02-28
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2013

A holdings report, amendment of type restatement, 60 entries on the cover page, a total value of $758,193,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $758,193,000 with VALUE read as thousands by filing date, 13F file number 028-14251. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DEPOMED INC249908104COM4,744,772$50,199,000thousands by filing date
LANNETT COMPANY INCORPORATED516012101COM1,339,945$44,352,000thousands by filing date
ANGIODYNAMICS INC03475V101COM2,497,049$42,849,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR841,736$33,737,000thousands by filing date
NOVADAQ TECHNOLOGIES INC COMMON66987G102COM1,969,634$32,479,000thousands by filing date
HORIZON PHARMA INC44047T109COM4,257,469$32,442,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON3,767,911$30,332,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK2,193,328$29,654,000thousands by filing date
ANACOR PHARMACEUTICALS INC032420101COM1,517,231$25,459,000thousands by filing date
EMERGENT BIOSOLUTIONS INC29089Q105COM1,074,048$24,692,000thousands by filing date
NATUS MEDICAL INC639050103COM1,014,116$22,818,000thousands by filing date
PROGENICS PHARMACEUTICALS IN743187106COM4,000,000$21,320,000thousands by filing date
ZOGENIX INC98978L105COM5,875,276$20,211,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK961,100$19,924,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM733,929$18,451,000thousands by filing date
DISCOVERY LABORATORIES INC N254668403COM NEW8,066,000$18,149,000thousands by filing date
IDERA PHARMACEUTICALS INC45168K306COM3,550,000$16,437,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM726,655$14,801,000thousands by filing date
CEMPRA INC15130J109COM1,164,547$14,429,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158102COM7,250,000$14,210,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK4,955,119$14,122,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM996,000$13,755,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM2,222,054$13,088,000thousands by filing date
NPS PHARMACEUTICALS INC62936P103COM400,000$12,144,000thousands by filing date
THERAPEUTICSMD INC88338N107COM2,128,159$11,088,000thousands by filing date
SOLTA MED INC83438K103COM3,356,391$9,901,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.01871,598$9,431,000thousands by filing date
DURECT CORP266605104COM5,440,290$9,412,000thousands by filing date
POZEN INC73941U102COMMON STOCK1,155,323$9,289,000thousands by filing date
LIBERATOR MEDICAL HLDGS INC53012L108COM2,169,531$9,047,000thousands by filing date
ATRICURE INC04963C209COM437,495$8,172,000thousands by filing date
SAGENT PHARMACEUTICALS INC786692103COM321,388$8,157,000thousands by filing date
XENCOR INC98401F105COMMON STOCK874,000$7,988,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM229,300$7,968,000thousands by filing date
VENTRUS BIOSCIENCES INC922822101COM1,849,839$7,066,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM391,232$7,027,000thousands by filing date
CHEMOCENTRYX INC16383L106COM1,033,668$5,985,000thousands by filing date
PAIN THERAPEUTICS INC69562K100COM1,230,000$5,978,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK543,466$5,435,000thousands by filing date
OPHTHOTECH CORP683745103COM150,000$4,853,000thousands by filing date
CARDICA INC14141R101COM4,772,672$4,653,000thousands by filing date
IGI LABORATORIES INC449575109COM1,500,000$4,575,000thousands by filing date
QLT INC746927102COMMON STOCK784,893$4,372,000thousands by filing date
TONIX PHARMACEUTICALS HOLDING890260201COM NEW392,952$4,051,000thousands by filing date
ANTARES PHARMA INC036642106COM800,000$3,577,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM214,286$3,564,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM1,000,000$3,319,000thousands by filing date
RITEAID CORP767754104COM500,000$2,530,000thousands by filing date
SYNERON MEDICAL LTDM87245102ORD200,000$2,460,000thousands by filing date
DURATA THERAPEUTICS INC26658A107COM188,706$2,414,000thousands by filing date
ANTHERA PHARMACEUTCLS INC03674U201Common equity shares766,329$2,353,000thousands by filing date
CAS MED SYS INC124769209COM1,349,796$2,295,000thousands by filing date
BIODEL INC09064M204COM1,000,000$2,280,000thousands by filing date
ACELRX PHARMACEUTICALS INC00444T100COM200,000$2,262,000thousands by filing date
CUTERA INC232109108COM215,962$2,198,000thousands by filing date
EPIZYME INC29428V104COM100,000$2,080,000thousands by filing date
TARGACEPT INC87611R306COM298,909$1,240,000thousands by filing date
DIGIRAD CORP253827109COM224,481$831,000thousands by filing date
TORNIER NVN87237108COMMON STOCK-FO15,000$282,000thousands by filing date
ST JUDE MED INC790849103COM100$6,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-14-001010 superseded2014-02-14acceptance time not in the bulk data set
13F-HR/A 0000919574-14-002012this filing2014-02-28acceptance time not in the bulk data set